Bollywood superstars Shah Rukh Khan, Ajay Devgn, and Tiger Shroff have landed in legal trouble. The Maharashtra Food and Drug Administration (FDA) has issued show-cause notices to the three actors over their association with a 2024 advertisement for Vimal Elaichi.
The state food safety authority alleges that the advertisement could amount to indirect or surrogate promotion of pan masala, which is prohibited in Maharashtra. This is a serious charge because surrogate advertising is a way brands use to promote products that are banned from direct advertising.
What the Maharashtra FDA notice demands from the actors
According to NDTV, Maharashtra's food safety chief Tukaram Mundhe sent a nine-page notice to the three actors. The notice asks them to discontinue their participation in the campaign and remove all promotional material related to the advertisement from their official social media accounts.
The actors have been given 15 days to explain their position. This means they must respond to the authorities with their side of the story within that timeframe, or face further action.
Why the Vimal Elaichi advertisement is under scrutiny
The core issue here is the distinction between a legitimate product advertisement and a surrogate promotion. Vimal Elaichi is marketed as an elaichi (cardamom) product, but the FDA believes the advertisement is actually promoting pan masala under the guise of a different product.
As reported by Rediff, the notice specifically targets the indirect promotion angle. This is a common regulatory concern in India, where tobacco-related products like pan masala face strict advertising restrictions.
"The state food safety authority has alleged that the advertisement could amount to indirect or surrogate promotion of pan masala, which is prohibited in Maharashtra." — NDTV
What this means for celebrity endorsements
This notice sends a strong signal to the entertainment industry. Celebrities who lend their faces to advertisements must now be more careful about what they endorse. The FDA's action against three of Bollywood's biggest names shows that regulatory bodies are serious about enforcing advertising rules.
According to Instagram reports, the show-cause notices have been issued specifically over the endorsement of Vimal Elaichi. The actors appeared together in the advertisement, which has now become a point of legal contention.
The YouTube coverage of this development highlights that the FDA is alleging indirect promotion, which is a violation of state regulations. This is not just about one advertisement — it sets a precedent for how similar cases might be handled in the future.
Our Take: A warning shot for surrogate advertising
In our view, this notice is a significant step in regulating how products with health implications are marketed. Surrogate advertising has been a grey area in Indian advertising for years. Brands often use look-alike products to keep their names in the public eye while avoiding direct promotion of banned substances.
The Maharashtra FDA's action against three top-tier celebrities makes it clear that regulators are now willing to hold individuals accountable, not just the companies behind the ads. This is a shift from the past, where celebrities often escaped scrutiny in such matters.
For the actors involved, the 15-day window to respond is crucial. They will need to either prove that the advertisement was genuinely for Vimal Elaichi as a standalone product, or face the consequences of being linked to surrogate promotion.
For the advertising industry, this is a moment to rethink strategies. Using celebrities to blur the lines between legal and illegal product promotion is no longer a safe bet. The message is simple: if a product cannot be advertised directly, using a similar-looking substitute with a celebrity face will not pass regulatory muster.
This case will be watched closely by everyone from brand managers to legal experts. The outcome could reshape how celebrity endorsements are structured in India, especially for products that sit close to regulated categories like pan masala.
As reported by Karnataka Times, the notices are for indirectly promoting Vimal Elaichi. The ball is now in the actors' court to respond within the given timeframe.
This development also raises questions about due diligence. Did the actors or their teams vet the advertisement properly before signing on? In an era where social media amplifies every endorsement, celebrities carry a responsibility to ensure their brand associations are legally sound.
The next 15 days will be telling. How the three actors respond — and what action the FDA takes next — will determine whether this becomes a landmark case in India's advertising regulation history.
Sources & References
- NDTV — Shah Rukh Khan, Ajay Devgn, Tiger Shroff Issued Notices Over Vimal Elaichi Ad
- Rediff — FDA Notice to SRK, Ajay Devgn, Tiger Shroff Over Vimal Elaichi Ad
- Instagram — Show-Cause Notices to SRK, Ajay Devgn, Tiger Shroff
- YouTube — Maharashtra FDA Issues Notices Over Vimal Elaichi Advertisement
- Karnataka Times — Maharashtra FDA Issued Show-Cause Notices